Neoleukin Therapeutics Inc (NASDAQ:NLTX)
| 0.625 Delayed Data As of Mar 24 |  +0.0002 / +0.03%Today’s Change | 0.38 Today|||52-Week Range 2.32 | +22.79% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Patel Priti /neoleukin/ Chief Medical Officer |  Sale | 2/02/2023 | 14,380 | $0.60 | $8.6K | +9.61% |
Patel Priti /neoleukin/ Chief Medical Officer | Sale | 5/02/2022 | 5,538 | $1.22 | $6.8K | -49.29% |
Smith Sean /neoleukin/ Principal Accounting Officer | Sale | 2/02/2023 | 3,316 | $0.60 | $2.0K | +9.61% |
Smith Sean /neoleukin/ Principal Accounting Officer | Sale | 8/10/2022 | 1,655 | $0.99 | $1.6K | -35.53% |
Patel Priti /neoleukin/ Chief Medical Officer |  Buy | 4/30/2022 | 10,000 | $0.00 | $0.00 | -49.29% |
Smith Sean /neoleukin/ Principal Accounting Officer | Buy | 8/10/2022 | 5,000 | $0.00 | $0.00 | -35.53% |
Patel Priti /neoleukin/ Chief Medical Officer | Buy | 2/01/2023 | 35,000 | $0.00 | $0.00 | +7.44% |
Smith Sean /neoleukin/ Principal Accounting Officer | Buy | 2/01/2023 | 12,500 | $0.00 | $0.00 | +7.44% |